There is evidence of reduction in lung cancer mortality in a high-risk population screened with LDCT. However, further evaluation is needed to assess the potential unintended harms, the practical implementation within the Nordic healthcare systems, and the environmental impact, including increased CO2 emissions.
Winsløw et al. (Tue,) studied this question.